LARTRUVO (Eli Lilly and Company)
Welcome to the PulseAid listing for the LARTRUVO drug offered from Eli Lilly and Company. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Eli Lilly and Company |
| NON-PROPRIETARY NAME: | olaratumab |
| SUBSTANCE NAME: | OLARATUMAB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2016-10-19 |
| END MARKETING DATE: | 0000-00-00 |
LARTRUVO HUMAN PRESCRIPTION DRUG Details:
| Item Description | LARTRUVO from Eli Lilly and Company |
| LABELER NAME: | Eli Lilly and Company |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/mL) |
| START MARKETING DATE: | 2016-10-19 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0002-7190_1742bd54-1adb-4528-9617-5a39f07dd957 |
| PRODUCT NDC: | 0002-7190 |
| APPLICATION NUMBER: | BLA761038 |
Other OLARATUMAB Pharmaceutical Manufacturers / Labelers:
